NASDAQ : MMED
Minimed Group, Inc. — Financial statements
Healthcare · Medical Instruments & Supplies · United States
Last price 18.28 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.14B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Minimed Group, Inc. (MMED) reported revenue of 3.22B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | 3.22B | 3.10B | 2.71B | 2.47B | 2.25B |
| Cost of Revenue | 1.39B | 1.33B | 1.19B | 1.03B | 929.00M |
| Gross Profit | 1.83B | 1.77B | 1.53B | 1.44B | 1.32B |
| Selling, General & Admin | 1.21B | 1.18B | 1.08B | 1.05B | 960.00M |
| Research & Development | 438.00M | 448.00M | 436.00M | 437.00M | 429.00M |
| Other Operating Expenses | 55.00M | 17.00M | -21.00M | 3.00M | -12.00M |
| Operating Expenses | 1.71B | 1.65B | 1.50B | 1.49B | 1.38B |
| Operating Income | 128.00M | 122.00M | 33.00M | -53.00M | -61.00M |
| Other Non Operating Income (Expenses) | 1.00M | -1.00M | -1.00M | -6.00M | |
| EBT Excluding Unusual Items | 128.00M | 123.00M | 32.00M | -54.00M | -67.00M |
| Merger & Restructuring Charges | -137.00M | -137.00M | -13.00M | -15.00M | -8.00M |
| Legal Settlements | -6.00M | -18.00M | -165.00M | ||
| Other Unusual Items | -157.00M | -157.00M | |||
| Pretax Income | -172.00M | -189.00M | -146.00M | -69.00M | -75.00M |
| Income Tax Expense | 129.00M | 128.00M | 52.00M | 38.00M | 16.00M |
| Earnings From Continuing Operations | -301.00M | -317.00M | -198.00M | -107.00M | -91.00M |
| Minority Interest in Earnings | -13.00M | -16.00M | -15.00M | -5.00M | -5.00M |
| Net Income | -314.00M | -333.00M | -213.00M | -112.00M | -96.00M |
| Net Income to Common | -314.00M | -333.00M | -213.00M | -112.00M | -96.00M |
| Shares Outstanding (Basic) | 263.65M | 256.60M | 252.80M | 252.80M | |
| Shares Outstanding (Diluted) | 263.65M | 256.60M | 252.80M | 252.80M | |
| EPS (Basic) | -1.19 | -1.30 | -0.84 | -0.44 | |
| EPS (Diluted) | -1.19 | -1.30 | -0.84 | -0.44 | |
| Free Cash Flow | -316.00M | -420.00M | -53.00M | -107.00M | -173.00M |
| Free Cash Flow Per Share | -1.20 | -1.64 | -0.21 | -0.42 | |
| Gross Margin | 56.89% | 57.06% | 56.28% | 58.24% | 58.62% |
| Operating Margin | 3.97% | 3.93% | 1.21% | -2.15% | -2.72% |
| Profit Margin | -9.74% | -10.73% | -7.85% | -4.54% | -4.28% |
| Free Cash Flow Margin | -9.81% | -13.54% | -1.95% | -4.33% | -7.71% |
| EBITDA | 286.00M | 278.00M | 176.00M | 76.00M | 54.00M |
| EBITDA Margin | 8.88% | 8.96% | 6.48% | 3.08% | 2.40% |
| D&A For EBITDA | 158.00M | 156.00M | 143.00M | 129.00M | 115.00M |
| EBIT | 128.00M | 122.00M | 33.00M | -53.00M | -61.00M |
| EBIT Margin | 3.97% | 3.93% | 1.21% | -2.15% | -2.72% |
Balance sheet
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 207.00M | 298.00M | 11.00M | 54.00M | 58.00M |
| Cash & Short-Term Investments | 207.00M | 298.00M | 11.00M | 54.00M | 58.00M |
| Accounts Receivable | 180.00M | 200.00M | 570.00M | 507.00M | 430.00M |
| Other Receivables | 602.00M | 455.00M | 1.00M | 1.00M | |
| Receivables | 782.00M | 655.00M | 570.00M | 508.00M | 431.00M |
| Inventory | 356.00M | 341.00M | 311.00M | 292.00M | 298.00M |
| Other Current Assets | 72.00M | 54.00M | 47.00M | 41.00M | 57.00M |
| Total Current Assets | 1.42B | 1.35B | 939.00M | 895.00M | 844.00M |
| Property, Plant & Equipment | 793.00M | 763.00M | 772.00M | 684.00M | 618.00M |
| Long-Term Investments | 75.00M | 75.00M | 75.00M | 76.00M | 80.00M |
| Goodwill | 2.25B | 2.26B | 2.25B | 2.25B | 2.25B |
| Other Intangible Assets | 100.00M | 107.00M | 132.00M | 161.00M | 194.00M |
| Long-Term Deferred Tax Assets | 58.00M | 61.00M | 19.00M | ||
| Long-Term Deferred Charges | 2.50M | ||||
| Other Long-Term Assets | 20.00M | 17.50M | 9.00M | 23.00M | 29.00M |
| Total Assets | 4.72B | 4.63B | 4.20B | 4.09B | 4.02B |
| Accounts Payable | 251.00M | 163.00M | 205.00M | 190.00M | 213.00M |
| Accrued Expenses | 251.00M | 294.00M | 297.00M | 281.00M | 253.00M |
| Current Portion of Leases | 9.00M | 8.00M | 11.00M | 8.00M | 7.00M |
| Current Income Taxes Payable | 34.00M | 38.00M | |||
| Current Unearned Revenue | 14.00M | 15.00M | 11.00M | 11.00M | 19.00M |
| Other Current Liabilities | 223.00M | 184.00M | 186.00M | 28.00M | 27.00M |
| Total Current Liabilities | 782.00M | 702.00M | 710.00M | 518.00M | 519.00M |
| Long-Term Leases | 50.00M | 45.00M | 56.00M | 41.00M | 23.00M |
| Long-Term Unearned Revenue | 5.00M | 4.00M | 3.00M | 6.00M | 4.00M |
| Long-Term Deferred Tax Liabilities | 7.00M | 4.00M | 4.00M | 4.00M | |
| Other Long-Term Liabilities | 261.00M | 261.00M | 98.00M | 77.00M | 68.00M |
| Total Liabilities | 1.10B | 1.02B | 871.00M | 646.00M | 618.00M |
| Common Stock | 3.00M | 3.00M | 3.46B | 3.41B | |
| Additional Paid-In Capital | 3.75B | 3.74B | |||
| Retained Earnings | -116.00M | -116.00M | 3.33B | ||
| Comprehensive Income & Other | -14.00M | -12.00M | 2.00M | -16.00M | -9.00M |
| Shareholders' Equity | 3.62B | 3.61B | 3.33B | 3.45B | 3.40B |
| Total Liabilities & Equity | 4.72B | 4.63B | 4.20B | 4.09B | 4.02B |
| Total Debt | 59.00M | 53.00M | 67.00M | 49.00M | 30.00M |
| Net Cash (Debt) | 148.00M | 245.00M | -56.00M | 5.00M | 28.00M |
| Net Cash Per Share | 0.56 | 0.95 | -0.22 | 0.02 | |
| Filing Date Shares Outstanding | 281.35M | 280.84M | 252.80M | 252.80M | |
| Total Common Shares Outstanding | 281.21M | 280.82M | 252.80M | 252.80M | |
| Working Capital | 635.00M | 646.00M | 229.00M | 377.00M | 325.00M |
| Book Value Per Share | 12.87 | 12.86 | 13.17 | ||
| Tangible Book Value | 1.26B | 1.25B | 943.00M | 1.03B | 953.00M |
| Tangible Book Value Per Share | 4.50 | 4.44 | 3.73 | ||
| Land | 7.00M | 7.00M | 7.00M | 7.00M | |
| Buildings | 232.00M | 233.00M | 214.00M | 213.00M | |
| Machinery | 480.00M | 395.00M | 342.00M | 339.00M | |
| Construction In Progress | 241.00M | 286.00M | 294.00M | 252.00M |
Cash flow statement
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Net Income | -314.00M | -333.00M | -213.00M | -112.00M | -96.00M |
| Depreciation & Amortization | 158.00M | 156.00M | 143.00M | 129.00M | 115.00M |
| Asset Writedown & Restructuring Costs | 84.00M | 84.00M | |||
| Stock-Based Compensation | 47.00M | 46.00M | 41.00M | 38.00M | 35.00M |
| Provision & Write-off of Bad Debts | 31.00M | 28.00M | 21.00M | 22.00M | 15.00M |
| Other Operating Activities | -23.00M | -12.00M | 26.00M | 38.00M | 15.00M |
| Change in Accounts Receivable | -65.00M | -83.00M | -66.00M | -105.00M | -70.00M |
| Change in Inventory | -14.00M | -29.00M | -19.00M | 5.00M | -28.00M |
| Change in Accounts Payable | 237.00M | 41.00M | 191.00M | -4.00M | 14.00M |
| Change in Other Net Operating Assets | -246.00M | -95.00M | 16.00M | 30.00M | -6.00M |
| Operating Cash Flow | -105.00M | -197.00M | 140.00M | 41.00M | -6.00M |
| Capital Expenditures | -211.00M | -223.00M | -193.00M | -148.00M | -167.00M |
| Investment in Securities | 6.00M | -13.00M | |||
| Other Investing Activities | -10.00M | -15.00M | |||
| Investing Cash Flow | -211.00M | -233.00M | -193.00M | -157.00M | -180.00M |
| Issuance of Common Stock | 538.00M | 538.00M | |||
| Common Dividends Paid | -229.00M | -229.00M | |||
| Other Financing Activities | 205.00M | 407.00M | 10.00M | 112.00M | 185.00M |
| Financing Cash Flow | 514.00M | 716.00M | 10.00M | 112.00M | 185.00M |
| Foreign Exchange Rate Adjustments | 1.00M | ||||
| Net Cash Flow | 198.00M | 287.00M | -43.00M | -4.00M | -1.00M |
| Free Cash Flow | -316.00M | -420.00M | -53.00M | -107.00M | -173.00M |
| Free Cash Flow Margin | -9.81% | -13.54% | -1.95% | -4.33% | -7.71% |
| Free Cash Flow Per Share | -1.20 | -1.64 | -0.21 | -0.42 | |
| Levered Free Cash Flow | -71.75M | 114.62M | -71.12M | ||
| Unlevered Free Cash Flow | -71.75M | 114.62M | -71.12M | ||
| Cash Income Tax Paid | 2.00M | 2.00M | |||
| Change in Working Capital | -88.00M | -166.00M | 122.00M | -74.00M | -90.00M |
Ratios
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Market Capitalization | 5.32B | 3.71B | |||
| Enterprise Value | 5.17B | 3.76B | |||
| Last Close Price | 18.90 | 13.20 | |||
| Forward PE | 31.20 | 43.29 | |||
| PS Ratio | 1.65 | 1.20 | |||
| PB Ratio | 1.47 | 1.03 | |||
| P/TBV Ratio | 4.20 | 2.97 | |||
| PEG Ratio | 1.83 | ||||
| EV/Sales Ratio | 1.60 | 1.21 | |||
| EV/EBITDA Ratio | 18.08 | 13.52 | |||
| EV/EBIT Ratio | 40.39 | 30.80 | |||
| Debt / Equity Ratio | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 |
| Debt / EBITDA Ratio | 0.20 | 0.18 | 0.36 | 0.57 | 0.48 |
| Net Debt / Equity Ratio | -0.04 | -0.07 | 0.02 | -0.00 | -0.01 |
| Net Debt / EBITDA Ratio | -0.52 | -0.88 | 0.32 | -0.07 | -0.52 |
| Net Debt / FCF Ratio | 0.47 | 0.58 | -1.06 | 0.05 | 0.16 |
| Asset Turnover | 0.70 | 0.66 | 0.61 | ||
| Inventory Turnover | 4.09 | 3.94 | 3.50 | ||
| Quick Ratio | 1.26 | 1.36 | 0.82 | 1.08 | 0.94 |
| Current Ratio | 1.81 | 1.92 | 1.32 | 1.73 | 1.63 |
| Return on Equity (ROE) | -8.66% | -9.13% | -5.84% | -3.12% | |
| Return on Assets (ROA) | 1.73% | 0.50% | -0.82% | ||
| Return on Capital Employed (ROCE) | 3.30% | 3.10% | 0.90% | -1.50% | -1.70% |
| Earnings Yield | -6.31% | -8.98% | |||
| FCF Yield | -5.94% | -11.33% | |||
| Buyback Yield / Dilution | -4.29% | -1.50% |